CASI PHARMACEUTICALS, INC. (CASIF) Free cash flow 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$20.8MFY2025 · since FY2020: -$27.4M → -$20.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.8M | +29.5% |
| FY2024 | -$29.4M | -46.0% |
| FY2023 | -$20.2M | +24.5% |
| FY2022 | -$26.7M | +25.4% |
| FY2021 | -$35.8M | -30.7% |
| FY2020 | -$27.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Net marginCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Capital expendituresCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →